Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|June 1, 2012
Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhoodDavide Paleari, Giovanni A Rossi, Gabriele Nicolini, et al.
Respiratory Medicine|September 29, 2018
Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary diseasePietro Pirina, Maria Pia Foschino Barbaro, Davide Paleari, et al.
Respiration; International Review of Thoracic Diseases|May 23, 2015
Effect of Ambroxol and Beclomethasone on Lipopolysaccharide-Induced Nitrosative Stress in Bronchial Epithelial CellsFabio L M Ricciardolo, Valentina Sorbello, Sabrina Benedetto, et al.
International Journal of Food Sciences and Nutrition|November 29, 2023
In vitro evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefenceBianca Papotti, Mattia Dessena, Maria Pia Adorni, et al.
Therapeutic Advances in Respiratory Disease|January 19, 2022
Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolutionFulvio Braido, Angelo G Corsico, Davide Paleari, et al.
Pulmonary Therapy|February 4, 2021
Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD PatientsRoberta Pisi, Marina Aiello, Alessio Piraino, et al.
Expert Opinion on Drug Delivery|June 20, 2020
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalersVeronica Chierici, Luca Cavalieri, Alessio Piraino, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2015
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary diseaseRoberta Pisi, Marina Aiello, Andrea Zanini, et al.
Pageof 2